The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
Author:
Publisher
BMJ
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology
Reference9 articles.
1. The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region;Van Schie;Ann Rheum Dis,2015
2. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD;Zitomersky;Inflamm Bowel Dis,2015
3. Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study;Warman;Eur J Gastroenterol Hepatol,2015
4. Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease;Pallagi-Kunstár;World J Gastroenterol WJG,2014
5. Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys;Rojas;J Pharmacol Exp Ther,2005
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Total terpenoids of Inula japonica activated the Nrf2 receptor to alleviate the inflammation and oxidative stress in LPS-induced acute lung injury;Phytomedicine;2022-12
2. Therapeutic Drug Monitoring in Practice for Inflammatory Bowel Disease;Current Gastroenterology Reports;2022-12
3. A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling;International Journal of Molecular Sciences;2022-03-22
4. Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab;Mediators of Inflammation;2017
5. Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits;Clinical Chemistry and Laboratory Medicine (CCLM);2016-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3